Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levetiracetam, quantity: 750 mg - tablet, film coated - excipient ingredients: maize starch; povidone; purified talc; colloidal anhydrous silica; magnesium stearate; titanium dioxide; sunset yellow fcf aluminium lake; iron oxide red; polyvinyl alcohol; macrogol 3350 - use in epiletpic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary genralisation, in patients from 16 years of age with newly diagnosed epilepsy. add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add-on therapy in the treatment of primary generalised tonic clonic (pgtc) seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levetiracetam, quantity: 500 mg - tablet, film coated - excipient ingredients: maize starch; povidone; purified talc; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - use in epiletpic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary genralisation, in patients from 16 years of age with newly diagnosed epilepsy. add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add-on therapy in the treatment of primary generalised tonic clonic (pgtc) seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levetiracetam, quantity: 250 mg - tablet, film coated - excipient ingredients: maize starch; povidone; purified talc; colloidal anhydrous silica; magnesium stearate; titanium dioxide; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - use in epiletpic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary genralisation, in patients from 16 years of age with newly diagnosed epilepsy. add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add-on therapy in the treatment of primary generalised tonic clonic (pgtc) seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

United States - English - NLM (National Library of Medicine)

ucb inc. - hydrocodone (unii: 6yks4y3wq7) (hydrocodone - unii:6yks4y3wq7), chlorpheniramine (unii: 3u6io1965u) (chlorpheniramine - unii:3u6io1965u) - hydrocodone 10 mg in 5 ml - tussionex pennkinetic extended-release suspension is indicated for the temporary relief of cough and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older. important limitations of use: - not indicated for pediatric patients under 18 years of age [see use in specific populations (8.4) ]. - contraindicated in pediatric patients less than 6 years of age [see contraindications (4) ]. - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1) ], reserve tussionex pennkinetic for use in adult patients for whom the benefits of cough suppression are expected to outweigh the risks, and in whom an adequate assessment of the etiology of the cough has been made. tussionex pennkinetic is contraindicated for: - all children younger than 6 years of age [see warnings and precautions (5.2, 5.3), use in specific populations (8.4) ]. tussionex pennkinetic is also contraindicated in patients with: -

United States - English - NLM (National Library of Medicine)

ucb, inc. - midazolam (unii: r60l0sm5bc) (midazolam - unii:r60l0sm5bc) - nayzilam is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient's usual seizure pattern in patients with epilepsy 12 years of age and older. nayzilam is contraindicated in patients with: - known hypersensitivity to midazolam. - acute narrow-angle glaucoma [see warnings and precautions (5.8)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as nayzilam, during pregnancy. healthcare providers are encouraged to recommend that pregnant women who are taking nayzilam during pregnancy enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/. risk summary neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal

Israel - English - Ministry of Health

neopharm ltd, israel - lacosamide - syrup - lacosamide 10 mg/ml - lacosamide - vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

chemvet australia pty ltd - abamectin - parenteral liquid/solution/suspension - abamectin anthelmintic active 10.0 mg/ml - parasiticides - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - brown stomach worm - ostertagia lyrata | cattle tick | hookworm - bunostomum phlebotomum | intestinal hair worm - t. colubriformis | intestinal threadworm - s. papillosus | large mouthed bowel worm | large stomach worm | longnosed cattle louse | lungworm - dictyocaulus viviparus | nodule worm - oesophagostomum radiatum | small brown stomach worm - o. ostertagi | small intestinal worm - cooperia spp. | stomach hair worm | thin necked intestinal worm-n. spathiger | barber's pole worm | black scour worm | including inhibited stages | large lungworm | long-nosed sucking louse | thin necked intestinal worm-ad

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - fenbendazole - oral solution/suspension - fenbendazole carbamate-benzimidazole active 25.0 g/l - parasiticides - cattle | goat | sheep | beef | billy | bos indicus | bos taurus | bovine | buck | buffalo | bull | bullock | calf | capra hircus - barber's pole worm - haemonchus spp. | barber's pole worm-haemonchus contortus | black scour worm - trichostrongylus spp. | hookworm - bunostomum phlebotomum | large lungworm - dictyocaulus filaria | large mouthed bowel worm | lungworm - dictyocaulus viviparus | nodule worm - oesophagostomum radiatum | nodule worm - oesophagostomum spp. | small brown stomach worm-ostertagia spp. | small intestinal worm - cooperia spp. | stomach hair worm | tapeworm - monieza expansa | thin necked intestinal worm | threadworm - capillaria spp. | whipworm - trichuris ovis | whipworm - trichuris spp. | hair worm | intestinal hair worm | large lungworm | pole worm | small hair worm | teladorsagia

Ireland - English - HPRA (Health Products Regulatory Authority)

ucb (pharma) ireland limited - isosorbide mononitrate - tablets - 20 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

ucb (pharma) ireland limited - isosorbide mononitrate - tablets - 10 milligram